Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome

Recent literature suggests that after non-myeloablative allogeneic (NMA) stem cell transplantation (SCT), the incidence of extramedullary (EM) relapse in multiple myeloma (MM) patients is increased and that these relapses have a poor prognosis. However, numbers on incidence and treatment outcome are...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2008-05, Vol.41 (9), p.779-784
Hauptverfasser:	Minnema, M C, van de Donk, N W C J, Zweegman, S, Hegenbart, U, Schonland, S, Raymakers, R, Zijlmans, J M J M, Kersten, M J, Bos, G M J, Lokhorst, H M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Autografts Biological and medical sciences Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction Care and treatment Cell Biology Chemotherapy Chromosome 13 Chromosome Deletion Chromosomes, Human, Pair 13 - genetics Diagnosis Disease-Free Survival Female Health aspects Hematology Homografts Humans Immunodeficiencies. Immunoglobulinopathies Immunoglobulinopathies Immunopathology Internal Medicine Living Donors Lymphocyte Transfusion Lymphocytes Male Medical prognosis Medical sciences Medicine Medicine & Public Health Middle Aged Multiple myeloma Multiple Myeloma - genetics Multiple Myeloma - mortality Multiple Myeloma - prevention & control original-article Patients Public Health Radiation therapy Recurrence Response rates Stem Cell Transplantation Stem Cells Survival Survival Rate Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation, Autologous Transplantation, Homologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!